Chemical agents, such as disulfonamide derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine, and similar heterocyclic ring structures, including salts thereof, that act as anti-cancer and anti-tumor agents, especially where such agents modulate the activity of the Wnt/β-catenin signaling pathway, and serve to reduce β-catenin levels present in cells, such as cancer cells, or where the agents modulate levels of gene expression in cellular systems, including cancer cells, are disclosed, along with methods for preparing such agents, as well as pharmaceutical compositions containing such agents as active ingredients and methods of using these as therapeutic agents.
本发明涉及一种
化学试剂,例如
芴,
蒽,黄色素,二苯基甲酮和
吖啶的二磺酰胺衍
生物,以及类似的杂环环结构,包括其盐,作为抗癌和抗肿瘤试剂,特别是这些试剂能够调节Wnt/β-连环蛋白信号通路的活性,降低细胞中(如癌细胞)的β-连环蛋白
水平,或者这些试剂调节
细胞系统(包括癌细胞)中
基因表达
水平。同时,本发明还涉及制备这些试剂的方法,以及包含这些试剂作为活性成分的制药组合物和使用这些组合物作为治疗试剂的方法。